US Stock MarketDetailed Quotes

KZR Kezar Life Sciences

Watchlist
  • 0.839
  • +0.014+1.70%
Close May 1 16:00 ET
  • 0.838
  • -0.001-0.06%
Post 19:48 ET
61.04MMarket Cap-598P/E (TTM)

About Kezar Life Sciences Company

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolKZR
Company NameKezar Life Sciences
Listing DateJun 21, 2018
Issue Price15.00
Founded2015
CEODr. Christopher Kirk, PhD
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-822-5600
Websitehttp://www.kezarlifesciences.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher Kirk, PhD
  • Director and Chief Executive Officer
  • 2.60M
  • Nicholas Michael Mordwinkin
  • Chief Business Officer
  • 1.76M
  • Mark C. Schiller
  • Chief Legal Officer
  • --
  • Marc L. Belsky
  • Chief Financial Officer and Secretary
  • 2.01M
  • Graham K. Cooper
  • Chairman of the Board
  • 194.56K
  • John Franklin Fowler
  • Director
  • 4.83M
  • Courtney Wallace
  • Independent Director
  • 164.59K
  • Franklin M. Berger, C.F.A.
  • Independent Director
  • 141.22K
  • Dr. Micki Klearman, M.D.
  • Independent Director
  • 161.58K
  • Dr. Elizabeth Garner, M.D.
  • Independent Director
  • 149.45K
  • Dr. Michael Glen Kauffman, M.D.,PhD
  • Independent Director
  • 155.34K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg